Amendment ID: S2898-18-R1

Redraft Amendment 18

Increased Access to SUD Treatment

Ms. Moran and Messrs. Payano and Tarr move that the proposed new text be amended by inserting after section 15 the following section:-

“SECTION 15A. (a) The bureau of substance use addiction services shall conduct a study on the potential benefits of expanding collaborative practice agreements between physicians and pharmacists to allow for the prescription of schedule II to VI, inclusive, controlled substances by pharmacists outside of the hospital or health care institution setting to treat patients with substance use disorders.

(b) The bureau shall study and report on: (i) collaborative practice agreements between physicians and pharmacists for the prescription of substances in collaborative practice agreements in other states; and (ii) the positive and negative impacts of allowing a collaborative practice agreement for schedule II to VI, inclusive, controlled substances.

(c) The department shall submit a report detailing the results of the study, along with recommendations and any proposed legislation necessary to carry out its recommendations, to the clerks of the senate and house of representatives, the joint committee on mental health, substance use and recovery, the joint committee on public health and the senate and house committees on ways and means not later than January 1, 2025.